Chapter 10 Purpura Haemorrhagica Flashcards

1
Q

What is purpura hemorrhagica (PH)?

A

An acute, non-contagious, aseptic necrotizing vasculitis characterized by edema and petechial or ecchymotic hemorrhage of the mucosa and subcutaneous tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What causes vasculitis in purpura hemorrhagica?

A

Deposition of antigen-antibody immune complexes on blood vessel walls.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What infections are commonly associated with purpura hemorrhagica?

A

Streptococcus equi subsp. equi, equine influenza, equine viral arteritis, equine herpesvirus type 1, Streptococcus equi subsp. zooepidemicus, Rhodococcus equi, and Corynebacterium pseudotuberculosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the typical clinical signs of purpura hemorrhagica?

A

Urticaria, pitting edema of the distal limbs, head and ventrum, petechial/ecchymoses of mucosal membranes, anorexia, lethargy, weight loss, depression, fever, tachycardia, tachypnea, stiffness, and reluctance to move.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the severe complications of purpura hemorrhagica?

A

Severe pneumonia, cardiac arrhythmias, renal failure, gastrointestinal complications, or severe muscle infarctions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the role of IgA in purpura hemorrhagica?

A

High IgA titers have been reported in horses with PH, suggesting its involvement in the disease pathophysiology.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the proposed hypotheses for high IgA and low IgG levels in PH?

A

Uncontrolled B cell expansion, liver failure to remove IgA, delayed IgG production, defective or suppressed IgG production, and neutralization or excess utilization of IgG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What histological findings are characteristic of leukocytoclastic vasculitis in PH?

A

Presence of an inflammatory infiltrate of neutrophils, nuclear fragmentation, extravasation of erythrocytes, and necrosis of vessel walls.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the key features of leukocytoclastic vasculitis?

A

Small-vessel inflammatory disease mediated by deposition of antibody-antigen immune-complexes, characteristic of hypersensitivity type III.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What diagnostic methods are used for purpura hemorrhagica?

A

History of recent respiratory infection, clinical signs, skin biopsy, and exclusion of other causes of vasculitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are common blood work findings in horses with purpura hemorrhagica?

A

Mild to moderate anemia, leukocytosis, neutrophilia, hyperproteinemia, hyperglobulinemia, and hyperfibrinogenemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What treatment protocol is recommended for purpura hemorrhagica?

A

Reducing inflammation with corticosteroids, removing the inciting cause, providing supportive care, and using antimicrobials like penicillin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the common drugs used for treating PH and their dosages?

A

Flunixin meglumine (1.1 mg/kg BID), phenylbutazone (2.2 mg/kg BID), dexamethasone (0.05–0.25 mg/kg BID or SID), and prednisolone (0.5–2 mg/kg BID or SID).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What supportive care measures are important in managing PH?

A

Bandaging swollen legs, caring for wounds, cold hydrotherapy, intravenous fluids, and tracheotomy if needed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the prognosis for horses with purpura hemorrhagica?

A

Prognosis improves with early and aggressive treatment, with an estimated case fatality rate of 10% with appropriate treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the common histological features of leukocytoclastic vasculitis in PH?

A

Neutrophil perivascular infiltration with pyknosis and karyorrhexis, extravasation of erythrocytes, and vessel wall necrosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the potential complications of prolonged immunosuppressive therapy in PH?

A

Increased risk of infections, laminitis, gastrointestinal issues, and delayed wound healing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the common clinical signs of systemic involvement in PH?

A

Colic, diarrhea, respiratory distress, and severe muscle infarctions.

19
Q

What are the typical clinical signs of severe head edema in PH?

A

Difficulty in breathing and eating, leading to anorexia, lethargy, and weight loss.

20
Q

What is the role of antimicrobial therapy in PH?

A

Treating underlying infections, especially with Streptococcus equi, using penicillin or other antimicrobials like trimethoprim-sulfamethoxazole and ceftiofur.

21
Q

What is the significance of elevated IgA titers in PH?

A

Elevated IgA titers to Streptococcus equi are suggestive of PH and may indicate an immune response to the infection.

22
Q

What is the role of anti-thrombotic agents in PH treatment?

A

Preventing thromboembolic complications using agents like pentoxifylline, low molecular weight heparin, and acetylsalicylic acid.

23
Q

What are the differential diagnoses for vasculitis in horses?

A

Drug or vaccine response, pastern and cannon leukocytoclastic vasculitis, photo-activated vasculitis, equine viral arteritis, equine infectious anemia, and others.

24
Q

What is the significance of early diagnosis and treatment in PH?

A

Improves prognosis, reduces complications, and prevents severe outcomes.

25
Q

What are the potential long-term outcomes for horses that recover from PH?

A

Generally good with appropriate treatment, but monitoring for recurrence and managing long-term complications is necessary.

26
Q

What is the importance of avoiding vaccination in horses with high SeM antibody titers?

A

To prevent triggering purpura hemorrhagica in horses with elevated antibody levels to Streptococcus equi.

27
Q

What are the common side effects of corticosteroid therapy in PH?

A

Laminitis, immunosuppression, and gastrointestinal issues.

28
Q

What are the clinical signs of purpura hemorrhagica?

A

Edema, petechial hemorrhage, anorexia, lethargy, weight loss, depression, fever, tachycardia, tachypnea, stiffness, and reluctance to move.

29
Q

What are the common histological findings in a skin biopsy of a horse with PH?

A

Leukocytoclastic vasculitis, neutrophil infiltration, nuclear fragmentation, extravasation of erythrocytes, and vessel wall necrosis.

30
Q

What are the typical blood work findings in horses with PH?

A

Mild to moderate anemia, leukocytosis, neutrophilia, hyperproteinemia, hyperglobulinemia, and hyperfibrinogenemia.

31
Q

What is the treatment protocol for PH?

A

Reducing inflammation with corticosteroids, providing supportive care, and using antimicrobials to treat underlying infections.

32
Q

What are the common drugs used for treating PH?

A

Flunixin meglumine, phenylbutazone, dexamethasone, and prednisolone.

33
Q

What is the prognosis for horses with PH?

A

Prognosis improves with early and aggressive treatment, with an estimated case fatality rate of 10% with appropriate treatment.

34
Q

What supportive care measures are important in managing PH?

A

Bandaging swollen legs, caring for wounds, cold hydrotherapy, and intravenous fluids.

35
Q

What is the role of anti-thrombotic agents in PH treatment?

A

Preventing thromboembolic complications using agents like pentoxifylline, low molecular weight heparin, and acetylsalicylic acid.

36
Q

What is the significance of elevated IgA titers in PH?

A

Elevated IgA titers to Streptococcus equi are suggestive of PH and may indicate an immune response to the infection.

37
Q

What are the differential diagnoses for vasculitis in horses?

A

Drug or vaccine response, pastern and cannon leukocytoclastic vasculitis, photo-activated vasculitis, equine viral arteritis, equine infectious anemia, and others.

38
Q

What is the importance of avoiding vaccination in horses with high SeM antibody titers?

A

To prevent triggering purpura hemorrhagica in horses with elevated antibody levels to Streptococcus equi.

39
Q

What are the potential complications of prolonged immunosuppressive therapy in PH?

A

Increased risk of infections, laminitis, gastrointestinal issues, and delayed wound healing.

40
Q

What are the clinical signs of systemic involvement in PH?

A

Colic, diarrhea, respiratory distress, and severe muscle infarctions.

41
Q

What is the role of antimicrobial therapy in PH?

A

Treating underlying infections, especially with Streptococcus equi, using penicillin or other antimicrobials like trimethoprim-sulfamethoxazole and ceftiofur.

42
Q

What are the common clinical signs of severe head edema in PH?

A

Difficulty in breathing and eating, leading to anorexia, lethargy, and weight loss.

43
Q

What are the potential long-term outcomes for horses that recover from PH?

A

Generally good with appropriate treatment, but monitoring for recurrence and managing long-term complications is necessary.

44
Q

What are the clinical signs of purpura hemorrhagica?

A

Edema, petechial hemorrhage, anorexia, lethargy, weight loss, depression, fever, tachycardia, tachypnea, stiffness, and reluctance to move.